right-img

Home | Investment Analysts’ Updated EPS Estimates for November, 20th (ALDR, AV, CELTF, CRH, DGLY, INCY, INFN, MOBL, PLUG, PMOIY)

Investment Analysts’ Updated EPS Estimates for November, 20th (ALDR, AV, CELTF, CRH, DGLY, INCY, INFN, MOBL, PLUG, PMOIY)

November 21, 2016
Investment Analysts’ updated eps estimates for Sunday, November 20th: Alder BioPharmaceuticals (NASDAQ:ALDR) had its buy rating reaffirmed by analysts at Jefferies Group. They currently have a $57.00 price target on the stock. Aviva PLC (NYSE:AV) had its hold rating reiterated by analysts at HSBC. Centamin Plc Com Npv (OTCMKTS:CELTF) had its hold rating reiterated by […]
Read more at:https://www.americanbankingnews.com/2016/11/20/investment-analysts-updated-eps-estimates-for-november-20th-aldr-av-celtf-crh-dgly-incy-infn-mobl-plug-pmoiy.html

Site Created by finaceandbankingnewsnow.com